Attached files

file filename
EX-21.1 - INTERPACE BIOSCIENCES, INC.ex21-1.htm
EX-32.2 - INTERPACE BIOSCIENCES, INC.ex32-2.htm
EX-32.1 - INTERPACE BIOSCIENCES, INC.ex32-1.htm
EX-31.2 - INTERPACE BIOSCIENCES, INC.ex31-2.htm
EX-31.1 - INTERPACE BIOSCIENCES, INC.ex31-1.htm
EX-10.45 - INTERPACE BIOSCIENCES, INC.ex10-45.htm
EX-10.44 - INTERPACE BIOSCIENCES, INC.ex10-44.htm
10-K - INTERPACE BIOSCIENCES, INC.form10-k.htm

 

EXHIBIT 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

Interpace Diagnostics Group, Inc.

Parsippany, New Jersey

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-207263) and Form S-8 (No. 333-61231, 333-60512, 333-177969, 333-201070, and 333-214260) of Interpace Diagnostics Group, Inc. of our report dated March 22, 2018, relating to the consolidated financial statements and financial statement schedule, which appear in this Form 10-K.

 

/s/ BDO USA, LLP

 

Woodbridge, New Jersey

March 23, 2018